Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
575 results about "Terpenoid" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The terpenoids (/ˈtɜːrpɪnɔɪd/ TUR-pin-oyd), sometimes called isoprenoids, are a large and diverse class of naturally occurring organic chemicals derived from terpenes. Most are multicyclic structures with oxygen-containing functional groups. About 60% of known natural products are terpenoids. Although sometimes used interchangeably with "terpenes", terpenoids contain additional functional groups, usually O-containing. Terpenes are hydrocarbons.
Solvent compositions for removing petroleum residue from a substrate and methods of use thereof
ActiveUS20050197267A1Cationic surface-active compoundsNon-ionic surface-active compoundsSpinning band distillationPetroleum
Water-soluble solvent compositions, including from about 10% to about 60% by weight of an aromatic ester; from about 30% to about 60% by weight of an aliphatic ester; from 0% to about 15% by weight of a co-solvent; from 0% to about 20% of one of a cyclic terpene and a terpenoid; from 0% to about 1% by weight of an odor-masking agent; and from 0% to about 20% by weight of a nonionic surfactant, for removing petroleum residue from a substrate, and methods of use thereof. The composition can further comprise water. The composition also can comprise an aqueous solution. The method for removing petroleum residue from a substrate can further comprise recycling the solvent composition by using a countercurrent separation column charged with compressed ammonia and / or carbon dioxide and a spinning band distillation column to separate the solvent composition from the petroleum residue.
Owner:CRUDE SPILL CLEANING CO INC
Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
InactiveUS6949582B1Good effectSafe and effectiveBiocideHydroxy compound active ingredientsSide effectCannabinoid receptor
A method of relieving analgesia and reducing inflammation using a cannabinoid delivery topical liniment composition containing from about 97.5% to about 99.5% by weight a 70% monohydric alcohol solution, and from about 0.5% to about 2.5% by weight of a synergistic cannabinoid mixture extracted from the female plant Cannabis sativa L, including in combination: 9-Tetrahydrocannabinol (delta-9-THC), 9-THC Propyl Analogue (THC-V), Cannabidiol (CBD), Cannabidiol Propyl Analogue (CBD-V), Cannabinol (CBN), Cannabichromene (CBC), Cannabichromene Propyl Analogue (CBC-V), Cannabigerol (CBG), terpenoids, and flavonoids. The liniment is applied topically, preferably by spraying, and the constituents of the mixture are absorbed through the skin and interact with cannabinoid receptors in the body and tissues of a human patient to produce therapeutic analgesic and anti-inflammatory effects without undesirable psychotropic side effects.
Owner:WALLACE WALTER H
Oral compositions and use thereof
InactiveUS20040057908A1Cosmetic preparationsToilet preparationsAphthous ulcerationsDental plaque formation
The present invention relates to an oral composition which includes an organoleptically suitable carrier and an amount of a terpenoid and a flavonoid, dispersed in the carrier, which is effective to prevent or treat dental caries, dental plaque formation, gingivitis, candidiasis, dental stomatitis, aphthous ulceration, or fungal infection. The invention also relates to various uses of oral compositions, containing a terpenoid, a flavonoid, or both, such uses include: inhibiting the activity of surface-bound glusosyltransferase; treating or inhibiting dental caries, gingivitis, candidiasis, denture stomatitis; inhibiting the accumulation of microorganisms on an oral surface; and / or treating or inhibiting aphthous ulcerations on an oral surface.
Owner:UNIV ESTADUAL DE CAMPINAS UNICAMP +1
Transgenic moss producing terpenoids
InactiveUS20100297722A1Reduced and eliminated and activityReduced and eliminated expressionFermentationVector-based foreign material introductionMossTerpenoid
Owner:SOUTHERN ILLINOIS UNIVERSITY +1
Antimicrobial Compositions
InactiveUS20080194518A1Improve antibacterial propertiesGood curative effectAntibacterial agentsBiocideCarbohydrate derivativeAmmonium compounds
An antimicrobial composition, including a synergistic combination of three or more agents as an active ingredient. Each of the three or more potentiating agents can be selected from the following types of compounds: sequestering agents, carbohydrates and carbohydrate derivatives, terpenes / terpenoids, amines and amine derivatives, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides and peroxide donors, and macrolide polyenes. At least two of the three or more potentiating agents are not of the same type of compound. The antimicrobial composition can have strong antimicrobial efficacy in control of microorganisms having resistance to currently used antimicrobials.
Owner:STERILEX TECH LLC
Terpene, terpenoid, and fullerene stabilizers for fluoroolefins
ActiveUS8101094B2Halogenated hydrocarbon separation/purificationHeat-exchange elementsAir conditioningSolvent
The present invention relates to compositions comprising at least one fluoroolefin and an effective amount of stabilizer that may be a terpene, terpenoid or fullerene; or a mixture of a terpene, terpenoid or fullerene with other stabilizers. The stabilized compositions may be useful in cooling apparatus, such as refrigeration, air-conditioning, chillers, and heat pumps, as well as in applications as foam blowing agents, solvents, aerosol propellants, fire extinguishants, and sterilants.
Owner:THE CHEMOURS CO FC LLC
Topical Delivery System for Phytosterols
This invention relates to certain sugar esters of phytosterols of formula (I). These esters are useful for topical application, and for the treatment of skin condition, including age spots, acne, loss of cellular antioxidants, collagen loss, loss of skin pliability, loss of skin suppleness, skin wrinkles including fine lines, oxidation, damage from radiation, malfunction of matrix metalloproteases, malfunction of tyrosinases, damage from free radicals, damage from UV, dry skin, xerosis, ichthyosis, dandruff, brownish spots, keratoses, melasma, lentigines, liver spots, pigmented spots, dark circles under the eyes, skin pigmentation including darkened skin, blemishes, oily skin, warts, eczema, pruritic skin, psoriasis, inflammatory dermatoses, topical inflammation, disturbed keratinization, skin changes associated with aging, nail or skin requiring cleansers, conditioning or treatment, and hair or scalp requiring shampooing or conditioning, and combinations thereof;Wherein,n=0, 1, 2, or 3; andR=H, —CH2OH, —CH(OH)—CH2OH, —CH(OH)—CH(OH)—CH2OH; andR1=Substituent selected from a sapogenin, steroid, or terpenoid.
Owner:BIODERM RES
Novel Method for the cheap, efficient, and effective production of pharmaceutical and therapeutic api's intermediates, and final products
InactiveUS20160298151A1Reduce concentrationFermentationDNA/RNA fragmentationBiotechnologyPhenylpropanoid
The present invention is a method for the biosynthesis of hundreds of compounds, mainly found in the cannabis plant. The starting material for these compounds can be any biological compound that is used / produced in a biological organism from the sugar family starting materials or other low cost raw materials processed via enzymes or within organisms to give final products. These final products include, but are not limited to: cannabinoids, terpenoids, stilbenoids, flavonoids, phenolic amides, lignanamides, spermidine alkaloids, and phenylpropanoids. Specifically, the present invention relates to the regular / modified / synthetic gene(s) of select enzymes are processed and inserted into an expression system (vector, cosmid, BAC, YAC, phage, etc.) to produce modified hosts. The modified host is then optimized for efficient production and yield via manipulation, silencing, and amplifying inserted or other genes in the host, leading to an efficient system for product.
Owner:BUTT SHER ALI +1
Stabilization of terpenoids in cosmetic compositions
InactiveUS6858217B2Improved storage/oxidative stabilityImprove stabilityCosmetic preparationsToilet preparationsOxidation stabilityNuclear chemistry
Cosmetic compositions containing terpenoids along with a 4-substituted resorcinol derivative exhibit improved storage stability and oxidative stability.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C
Antimicrobial compositions
InactiveUS20090312279A1Improve antibacterial propertiesGood curative effectBiocideHydrocarbon active ingredientsCarbohydrate derivativeAmmonium compounds
An antimicrobial composition, including a synergistic combination of three or more agents as an active ingredient. Each of the three or more potentiating agents can be selected from the following types of compounds: sequestering agents, carbohydrates and carbohydrate derivatives, terpenes / terpenoids, amines and amine derivatives, plant-derived oils, sulfonates, phenols, fatty acids, dibenzofuran derivatives, organo isothiocyanates, quaternary ammonium compounds, peroxides and peroxide donors, and macrolide polyenes. At least two of the three or more potentiating agents are not of the same type of compound. The antimicrobial composition can have strong antimicrobial efficacy in control of microorganisms having resistance to currently used antimicrobials.
Owner:STERILEX TECH LLC
System For Producing Terpenoids In Plants
InactiveUS20080281135A1Increase productionOther foreign material introduction processesLiquid hydrocarbon mixture productionTerpene synthaseHeterologous
The invention concerns a method for producing terpenes of interest in plants having glandular trichomes, as well as plants useful for producing said terpenes of interest. Said plants comprise a sequence encoding a heterologous terpene synthase under the control of a promoter enabling it to be specifically expressed in the trichomes. Moreover, the pathway for producing endogenous diterpenes is preferably blocked in the trichomes of the plants, to increase the flow in the heterologous pathway. The secretion of heterologous terpenes is spontaneous resulting in easy collection. The present invention also concerns plants exhibiting a blocked production of a compound having antibiotic properties at the surface of leaves exhibiting enhanced efficiency of transformation by a bacterium.
Owner:PHILIP MORRIS PROD SA
Herbal smoking blend
The disclosed embodiments relate generally to herbal smoking blends and methods for preparing and using herbal smoking blends, and relate more particularly to herbal smoking blends having terpenoids added thereto. In one aspect, a method of preparing an herbal smoking blend comprises providing a smoking herb preparation. The method additionally comprises providing a terpenoid solution comprising a terpenoid. The terpenoid solution may be added to the smoking herb preparation to, for example, provide a smoking herb preparation that achieves a desired effect on a consumer of the preparation.
Owner:OPEN BOOK EXTRACTS
Mixed gel for injection and preparation method thereof
The invention relates to a mixed gel applied to injection and a preparation method thereof. The mixed gel of the invention is characterized by comprising polyaspartic acid terpenoid gel particle, cross bonding hyaluronic acid gel particle and hyaluronic acid or salt solution thereof, wherein, the volume of the polyaspartic acid terpenoid gel particle accounts for 5-80%, the volume ratio of the cross bonding hyaluronic acid gel particle and hyaluronic acid or salt solution thereof ranges from 1:19-19:1; the preparation method of the mixed gel has the following steps: respectively preparing the polyaspartic acid terpenoid gel particle and cross bonding hyaluronic acid gel particle; mixing evenly the particles with hyaluronic acid dissolved in the isosmotic solution after full swelling and balancing in isosmotic solution, sterilizing and packaging the mixture to obtain the finished product. The mixed gel of the invention can be used to prepare injection for beauty care and medical treatment and has the characteristics of long hold time and little side effect.
Owner:SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES
Agricultural combination solvent and application thereof
InactiveCN102524246AImprove solubilityGood compatibilityBiocidePlant growth regulatorsGrowth plantSolvent
The invention provides an agricultural combination solvent which comprises a terpenoid and C8-C18 fatty acid esters. The agricultural combination solvent has good compatibility with pesticides, is safe and environment-friendly, has good biodegradation, has no pollution, has low freezing point and high flash point, and is safe and reliable in production, storage, transportation and use. The agricultural combination solvent can be applied in insecticides, herbicides or / and plant growth regulators.
Owner:FUJIAN NUODE BIOTECH
Device and process for the recovery of increased volumes of pure terpenes and terpenoids from scrap polymers and elastomers
Owner:BEAVER EARL R +1
Purification of acetic acid from wood acetylation process using extraction
InactiveUS20090234157A1Organic compound preparationCarboxylic compound separation/purificationAcetic acidOrganosolv
There is shown a method of purifying glacial acetic acid containing terpene and terpenoid impurities. Substantially dry acetic acid containing terpene and terpenoid impurities is combined with water and a suitable organic solvent, which is substantially immiscible with acetic acid and water, to form a separating composite extraction medium having a weight ratio of acetic acid:water of at least 1:1. The components are separated into an organic phase and an aqueous acid phase, with the terpene and terpenoid impurities concentrated in the organic phase, and with the aqueous acid phase purified of terpene and terpenoid impurities. The purified aqueous acid phase is recovered, and the purified acetic acid is dried.
Owner:RNK PROD INC +1
Lighter fluid composition
InactiveUS6843812B2Clean burningLow VOC emissionSolid fuelsLiquid carbonaceous fuelsCross-linkMethanol
A lighter fluid composition usable for starting barbecues and the like that comprises naturally occurring combustible materials, which is clean burning and results in low volatile organic compound (VOC) emission during combustion, which is biodegradable and easily disposable, and which burns with a pleasant aroma and does not impart any unpleasant hydrocarbon odor or flavor to food cooked on a barbecue. The composition preferably comprises between approximately 0.5 weight percent and approximately 90 weight percent of a terpene or terpenoid oil, and between approximately 0.5 weight percent and approximately 98.5 weight percent of short chain alcohol, between approximately 0.5 weight percent and approximately 60 weight percent of water, between approximately 0.1 weight percent and approximately 10 weight percent of surfactant, and between approximately 0.5 weight percent and approximately 10 weight percent of thickening agent. The preferred terpene preferably comprises d-limonene or a citrus derived oil containing d-limonene such as cold-pressed orange oil. The preferred alcohols are methanol and ethanol. The preferred surfactant is a non-ionic detergent or detergents, and the preferred thickener is a pH controllable slightly cross-linked polyacrylic acid material.
Owner:STEPHANOS PRODROMOS PERICLES
Composition for selective serotonin reuptake inhibition and process thereof
The present invention relates to a novel pharmaceutical composition for serotonin reuptake inhibition, wherein the composition comprises pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients. Also the present invention relates to a process of preparation of novel pharmaceutical composition for serotonin reuptake inhibition, wherein the process comprising steps of: (a) obtaining extract from the plant Centella asiatica; (b) treating the extract with the solvents to remove fatty substances, chlorophyll and other colorants; (c) purifying the extract through HPLC to obtain the eluted solvent; and (d) concentrating the eluted solvent to arrive at the composition. The invention also relates to the use of a composition comprising pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients to manufacture a medicament for serotonin reuptake inhibition in a subject in need thereof.
Owner:INDUS BIOTECH PVT
Gene promoter of ginseng PgPDR3 responded by methyl jasmonate and application thereof
InactiveCN103103194AVector-based foreign material introductionAngiosperms/flowering plantsNicotiana tabacumSalicylic acid
The invention discloses a gene promoter of ginseng PgPDR3 responded by methyl jasmonate and an application thereof. The sequences of the gene promoter of the ginseng PgPDR3 are shown in SEQ ID NO.1, or are the DNA sequences of which the homology with SEQ ID NO.1 is over 99%. According to the invention, a Genomewalker technology is adopted to clone, later the sequences of the gene promoter of the PDR transport protein is obtained, and then the expression vector Pcambia1301-ProPDR3::GUS of the promoter is built; if the promoter in the transgenic tobacco drives the GUS to express, and can be controlled by ginsenoside, salicylic acid, gibberellins and abscisic acid, the promoter participates in the transport and accumulation of the ginsenoside, which provides a basis for cloning the gene of key control recording factor in the ginsenoside transport signal pathway and controlling the transport and accumulation of the terpenoid, such as ginsenoside; and fine plants containing rich ginsenoside can be obtained by using a method for controlling or improving the ginseng and other plants via the promoter or the derivative thereof.
Owner:CENT SOUTH UNIV
Limonene, pinene, or other terpenes and their alcohols, aldehydes and ketones, as polymer solvents for conducting polymers in aqueous and non-aqueous coating formulations and their uses
A low-VOC (volatile organic compound) and / or low-toxicity coating formulation, including at least one non-halogenated solvent including terpene(s) or terpenoid(s), and at least one polymer including conducting polymers, electroactive polymers and / or conjugated polymers, wherein the polymers and non-halogenated solvent(s) are in non-aqueous form. In other embodiments, coating formulations, includes about 0.01% wt. to about 99.9% wt. of at least one non-halogenated solvent including a terpene or terpenoid, about 0.01% wt. to about 90% wt. of at least one polymer including conducting polymers, conjugated polymers, and electroactive polymers, and about 0.001% wt to about 90% wt. of at least one surfactant, wherein the polymers, solvents, and surfactants are in non-aqueous form. Also included are aqueous low VOC and / or toxicity coating formulations having at least one non-halogenated solvent including terpene(s) or terpenoid(s), and at least one conjugated, electroactive, or conductive polymer, copolymer, block polymer, and mixtures thereof.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC OF THE NAVY NAVAL RES LAB WASHINGTON
Ophthalmic composition
InactiveUS20100239518A1Relieve pressureImproving eye drynessSenses disorderHydroxy compound active ingredientsCelluloseEye dryness
The present invention provides an ophthalmic composition which stabilizes the tear film during wearing contact lens, prevents eye dryness, imparts a favorable sensation in using, is highly convenient with no risk of misuse and shows a high efficiency in the course from manufacturing to sales. More specifically, the present invention provides a wetting solution—eye drops for contact lenses comprising (A) one or more member (s) selected from the group consisting of a cellulose-based polymer, a vinyl-based polymer, polyethylene glycol and dextran; and (B) a terpenoid.
Owner:ROHTO PHARM CO LTD
Microbial Engineering For The Production Of Chemical And Pharmaceutical Products From The Isoprenoid Pathway
ActiveCN102812129AFermentationVector-based foreign material introductionMicroorganismTaxadiene synthase
The invention relates to recombinant expression of a taxadiene synthase enzyme and a geranylgeranyl diphosphate synthase (GGPPS) enzyme in cells and the production of terpenoids.
Owner:MASSACHUSETTS INST OF TECH +1
Glycosyl transferases and applications of glycosyl transferases
ActiveCN104232723ASpecific and efficient transferHas anticancer activityTransferasesFermentationTriterpeneCoa transferase
The invention relates to a group of glycosyl transferases and applications of the glycosyl transferases. Particularly, the invention provides applications of glycosyl transferases gGT25, gGT13, gGT30, gGT25-1, gGT25-3, gGT25-5, gGT29, gGT29-3, gGT29-4, gGT29-5, gGT29-6, gGT29-7, 3GT1, 3GT2, 3GT3 and 3GT4, and derived peptides of the glycosyl transferases in glycosylation catalysis and new saponin synthesis of terpenoids. The glycosyl transferases can specifically and efficiently catalyze hydroxyl glycosylation of C-20 bit and / or C-6 bit and / or C-3 of a tetracyclic triterpenoid compound substrate, and / or transfers the glycosyl groups from glycosyl donors to the first glycosyl groups of the C-3 bit and C-6 bit of the tetracyclic triterpenoid compound to extend a carbohydrate chain. The glycosyl transferases disclosed by the invention can also be applied to building synthetic rare ginsenosides and a plurality of novel ginsenosides and derivatives of the ginsenosides.
Owner:SYNBIOTECH (SUZHOU) CO LTD
Ophthalmic composition for soft contact lens comprising terpenoid
ActiveUS20100011989A1Avoid deformationImprove wettabilityBiocideSenses disorderOphthalmologyAlginic acid
Disclosed is an ophthalmic composition for a soft contact lens, which is characterized in that the adsorption of a terpenoid contained in the composition onto a soft contact lens is reduced. The ophthalmic composition comprises a combination of Component (A) 0.005 to 0.01 wt % of a terpenoid and Component (B) alginic acid and / or a salt thereof.
Owner:ROHTO PHARM CO LTD
Method for preparing active algae extract foliar fertilizer
Owner:ZHEJIANG OCEAN UNIV
Stabilization with substituted ureas against color degradation of personal care products
A personal care product is provided which includes an unsaturated organic material with at least one olefinic double bond susceptible to degradation into a color bearing substance, the unsaturated material being selected from C10-C50 terpenoids and C12-C48 unsaturated fatty compounds selected from the group consisting of fatty alcohols, fatty acids, fatty acid glycerides, fatty acid salts and combinations thereof, a substituted urea as a stabilization agent to prevent color body formation, and a cosmetically acceptable carrier. Particularly useful as a stabilizing agent is hydroxyethyl urea.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C
System and method for analyzing polycyclic terpane in petroleum geological sample
The invention discloses a system and a method for analyzing polycyclic terpane in a petroleum geological sample. The system comprises a central processing unit, a mass spectrograph and a chromatograph, wherein the central processing unit is connected with the chromatograph through the mass spectrograph; the chromatograph comprises a vaporizing chamber and two chromatographic columns with different polarities; the sample enters the two chromatographic columns in turn for separation after passing through the vaporizing chamber in the chromatograph; each separated component substance enters the mass spectrograph in turn to form fragment ions; and the central processing unit qualitatively and quantitatively analyzes the component according to the distribution characteristic of the fragment ions and forms a chromatographic mass spectrum image. In the system and the method, by preferably and effectively combining the two chromatographic columns with different polarities, tricyclic terpenoids, tetracyclic terpenoids and pentacyclic terpenoids in saturated hydrocarbon component of crude oil or rock extract are effectively separated and qualitatively and quantitatively analyzed on the basis of optimized modulation period and analysis conditions.
Owner:CHINA PETROLEUM & CHEM CORP +1
Use of cyclic enol ether terpenoid for producing promotive neurocyte proliferate and differentiation medicament
Owner:XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI
Terpenoid and application thereof in medicine
The invention relates to a terpenoid and an application thereof in medicines, and in particular relates to a new terpenoid, or an isomer, a medicinal salt, a hydrate or a solvate thereof, and an application thereof in medicines. Specifically, the invention relates to a terpenoid as shown in a general formula (I), or an isomer, a medicinal salt, a hydrate or a solvate thereof, and the application of the terpenoid, and the isomer, the medicinal salt, the hydrate or the solvate of the terpenoid in preparing drugs for treating renal / kidney diseases (RKD), insulin resistance, diabetes, complications related to diabetes, endothelial dysfunction, nonaalcoholic fatty liver diseases or cardiovascular diseases (CVD).
Owner:UNITRIS BIOPHARMA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com